The Use of Diffuse Optical Spectroscopy to Characterize in Response to Weight-Loss Intervention
Status
Conditions
Treatments
Details and patient eligibility
About
The first step in any clinical intervention against obesity involves sustained lifestyle changes. Researcher can use these strategies to beneficial the effects of weight and on cardiovascular risk. The researcher develope methods for assessing the effectiveness use optical technology to make such assessments, specifically in the area of fatty tissue can predict the effectiveness of the intervention in causing weight reduction and treating metabolic disease.
Full description
Optical technologies under development at the Beckman Laser Institute.
Diffuse Optical Spectroscopy Imaging is a method for studying absorption and scattering (optical properties) of tissue in humans. It is related to near-infrared spectroscopy , but allows for more quantitative and thorough measurements. The researcher use Diffuse Optical Spectroscopy to measure fatty tissue, water, blood concentration level during weight loss program to determine the effect of sustained changes in weight or relapses.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Body Mass Index greater than 25, overweight
- Participation in Weight Loss program
Exclusion criteria
- A medical history of myocardial infarction or cerebrovascular stroke
- Pregnancy or planned pregnancy during the course of the study period
Trial design
21 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal